Perturbation of generation cycle of human leukaemic blast cells in vivo by daunomycin.
D000328:Adult; D000368:Aged; D001345:Autoradiography; D001772:Blood Cell Count; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D002455:Cell Division / Q000187:drug effects; D002467:Cell Nucleus / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D003630:Daunorubicin / Q000494:pharmacology* / Q000627:therapeutic use; D003864:Depression, Chemical; D005260:Female; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D007945:Leukemia, Lymphoid / Q000097:blood* / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D008938:Mitosis / Q000187:drug effects*; D013053:Spectrophotometry; D013268:Stimulation, Chemical; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D014316:Tritium; D004247:DNA; D013936:Thymidine; D003630:Daunorubicin